Hikma Pharmaceutical | HIK - Assets

Stock Price
1,280.50
Daily Change
14.50 1.15%
Monthly
-21.44%
Yearly
-37.78%
Q1 Forecast
1,214.21

Hikma Pharmaceutical reported $5.67B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Almirall EUR 2.34B 29.21M Dec/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Autolus Therapeutics Ltd USD 661.95M 59.03M Sep/2025
Bayer EUR 104.54B 331M Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 6.46B 122M Jun/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 51.53B 600M Dec/2025
Orion EUR 2.01B 262M Dec/2025
Recordati EUR 5.3B 122.58M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 17.35B 1.72B Dec/2024